Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Restrictive substitution of coagulation factors and blood products in liver cirrhosis
2021-006870-22Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Sep 2022
- Modality
- Cell Therapies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Human prothrombin complex, Prothromplex Total, platelets and prothrombin complex concentrate in Cirrhosis, sponsored by Medical University of Vienna. Primary endpoint: incidence of bleeding complications. Started Sep 2022; status: completed.
02
Drugs
Human prothrombin complexProthromplex Totalplateletsprothrombin complex concentrate
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on 2021-006870-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006870-22.